AxoGen AXGN 深 沪
已收盘 10-09 16:00:00 美东时间
36.13
-0.050
-0.14%
华盛通- 最 高36.80
- 今 开36.35
- 成交量 92.98万股
- 最 低 35.60
- 昨 收 36.18
- 总市值 21.20亿
- 52周最高 52.91
- 市盈率 静 --
- 换手率 1.58%
- 52周最低 16.65
- 委 比 -28.57%
- 总股本 5867.15万
- 历史最高 56.85
- 量 比 0.44
- 振 幅 3.32%
- 历史最低 1.10
- 每 手 1
- 风险率 8.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio
AxoGen ( ($AXGN) ) just unveiled an update. On October 1, 2026, AxoGen complete...
10-02 05:49
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut the price target for WW Grainger Inc (NYSE:GWW) from $1,185 to $1,172. Barclays analyst Guy Hardw...
09-25 20:56
Raymond James Maintains Outperform on Axogen, Raises Price Target to $53
Raymond James analyst Jayson Bedford maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $48 to $53.
09-25 20:29
2亿美元！神经修复巨头押注这一全球首款
（来源：医疗器械创新网） 导语：Axogen以2亿美元收购BioCircuit，拿下FDA首款经510(k)许可的无缝合神经修复器械。神经修复的器械替代，正从替...
09-11 19:09
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash. The strategic acquisition integrates NerveTape, the first FDA-approved sutureless nerve repair device, into Axogen’s existing surgical solutio...
09-11 00:31
Axogen Prices $208.7M Underwritten Public Offering Of 4.91M Shares At $42.50 Per Share
Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an underwritten public offering of 4,910,000 shares of its common stock at a price to the...
09-10 18:06
美股大行评级 | 潜在涨幅1849.95%！Ascendiant Capital上调IGC Pharma目标价至6美元，维持"买入"评级；迪克体育、财捷遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.5美元升至6美元；Ascendiant Capital：维持Quantum Computing"买入"评级，目标价从30美元升至32美元
08-27 08:37
Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60
Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $60.
08-26 21:58
